Latest for Hemophilia B
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
- Trial sites5 new sites opened for Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene… (Phase 3, Pfizer)ClinicalTrials.gov
- Label changeThe FDA approved a label update for HympavziFDA
More about Hemophilia B
Severe disease (<1% factor activity) causes spontaneous bleeding into joints and muscles without provocation; moderate disease (1-5% activity) causes bleeding with minor trauma and progressive joint disease; mild disease (5-40% activity) causes bleeding only with significant trauma or surgery. Joint bleeds (hemarthrosis) cause hemarthropathy with chronic pain and joint destruction if untreated. Spontaneous intracranial hemorrhage and other serious bleeding episodes represent major morbidity.
Keep reading about Hemophilia B
Diagnosis requires factor IX activity assay showing reduced levels. The condition accounts for approximately 15-20% of all hemophilia cases. Factor IX deficiency results in the same bleeding phenotype as factor VIII deficiency, distinguishable only by specific factor assays. Most affected males have severe disease.
What are the symptoms of Hemophilia B?
These are common symptoms of Hemophilia B, and how strong they are varies from person to person.
- Easy bruising and bleeding
- Hemarthrosis (joint bleeds) causing pain and swelling
- Muscle hematomas
- Spontaneous bleeding in severe forms
- Bleeding after trauma or surgery
- Oral and GI bleeding
Who gets Hemophilia B?
Affects males predominantly with estimated prevalence of 1 in 25,000-33,000 males worldwide. Very rare in females, occurring only in special circumstances. Hemizygous males have severe disease; heterozygous females rarely develop symptoms.
All ethnic and racial groups affected with similar incidence. No significant geographic variation in prevalence identified. Approximately 20% of hemophilia B cases represent de novo mutations. Family history crucial for carrier identification and genetic counseling.
Next steps: find trials you might fitcompare treatmentsget help payingget alerts
Which medicines are FDA-approved for Hemophilia B?
There are currently 11 FDA-approved medications for Hemophilia B.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
How to get help paying for Hemophilia B treatment
Charity funds and drugmaker programs for Hemophilia B, checked at the source.
- From a charity · Hemophilia Federation of AmericaHelping Hands Program fundOpen
Pays for: Emergency living expenses ($250 prepaid card, once per year; referral through HTC or member organization; does not cover medical bills, copays or premiums), up to $250 per year.
The foundation says: “The Helping Hands program is now open on a limited basis for 2026. Due to funding constraints, a maximum of 20 requests will be approved…” - From a charity · TotalAssist (formerly PAN Foundation)Hemophilia fundOpen
Pays for: Out-of-pocket costs for approved medications, up to $12,500 per year. Requires health insurance (any kind).
- From a charity · The Assistance FundHemophilia fundWaitlist
Pays for: Copays, coinsurance, deductibles and other health-related expenses.
- Alhemo (Concizumab) · NovoCare (Rare Bleeding Disorders)
- Hympavzi (Marstacimab) · Pfizer Hemophilia Connect
- Qfitlia (Fitusiran) · Sanofi HemAssist
- Hemgenix (Etranacogene dezaparvovec) · HEMGENIX Connect
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Hemophilia B
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Hemophilia B resources
Reputable organizations and medical references for learning more about Hemophilia B, including disease registries, foundation resources, and clinical guidelines.